Melanin-koncentrirajući hormonski receptor 1

Iz Wikipedije, slobodne enciklopedije
Idi na navigaciju Idi na pretragu
edit
Melanin-koncentrirajući hormonski receptor 1
Identifikatori
SimboliMCHR1; GPR24; MCH1R; MGC32129; SLC1
Vanjski IDOMIM601751 MGI2180756 HomoloGene21097 IUPHAR: MCH1 GeneCards: MCHR1 Gene
Pregled RNK izražavanja
PBB GE MCHR1 221354 s at tn.png
podaci
Ortolozi
VrstaČovekMiš
Entrez2847207911
EnsemblENSG00000128285ENSMUSG00000050164
UniProtQ99705Q3UY93
RefSeq (mRNA)NM_005297NM_145132
RefSeq (protein)NP_005288NP_660114
Lokacija (UCSC)Chr 22:
39.41 - 39.41 Mb
Chr 15:
81.06 - 81.07 Mb
PubMed pretraga[1][2]

Melanin-koncentrirajući hormonski receptor 1, takođe poznat kao MCH1, je jedan od ljudskih melanin-koncentrirajućih hormonskih receptora.[1]

Protein kodiran ovim genom je član G protein-spregnuti receptor familije 1. On je integralni protein membrane plazme koji vezuje melanin-koncentrirajući hormon. Ovaj receptor može da inhibira cAMP akumulaciju, i da stimuliše intracelularni kalcijum fluks. Smatra se da on učestvuje u neuronalnoj regulaciju konzumacije hrane. Mada je strukturno sličan sa somatostatin receptorima, ovaj protein ne vezuje somatostatin.[1]

Funkcija[uredi - уреди | uredi izvor]

MCH1 ima brojne funkcije, u koje se ubrajaju regulacija apetita,[2][3] kao i posredovanje stresa, strepnje i depresije.[4][5][6][7][8][9]

Selektivni Ligandi[uredi - уреди | uredi izvor]

Agonisti[uredi - уреди | uredi izvor]

Antagonisti[uredi - уреди | uredi izvor]

Vidi još[uredi - уреди | uredi izvor]

Reference[uredi - уреди | uredi izvor]

  1. 1,0 1,1 "Entrez Gene: MCHR1 melanin-concentrating hormone receptor 1". http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=2847. 
  2. Luthin DR (July 2007). "Anti-obesity effects of small molecule melanin-concentrating hormone receptor 1 (MCHR1) antagonists". Life Sciences 81 (6): 423–40. PMID 17655875. doi:10.1016/j.lfs.2007.05.029. 
  3. Rivera G, Bocanegra-García V, Galiano S, Cirauqui N, Ceras J, Pérez S, Aldana I, Monge A (2008). "Melanin-concentrating hormone receptor 1 antagonists: a new perspective for the pharmacologic treatment of obesity". Current Medicinal Chemistry 15 (10): 1025–43. PMID 18393860. doi:10.2174/092986708784049621. 
  4. Hervieu G (August 2003). "Melanin-concentrating hormone functions in the nervous system: food intake and stress". Expert Opinion on Therapeutic Targets 7 (4): 495–511. PMID 12885269. doi:10.1517/14728222.7.4.495. 
  5. Shimazaki T, Yoshimizu T, Chaki S (2006). "Melanin-concentrating hormone MCH1 receptor antagonists: a potential new approach to the treatment of depression and anxiety disorders". CNS Drugs 20 (10): 801–11. PMID 16999451. 
  6. Hervieu GJ (April 2006). "Further insights into the neurobiology of melanin-concentrating hormone in energy and mood balances". Expert Opinion on Therapeutic Targets 10 (2): 211–29. PMID 16548771. doi:10.1517/14728222.10.2.211. 
  7. Smith DG, Davis RJ, Rorick-Kehn L, Morin M, Witkin JM, McKinzie DL, Nomikos GG, Gehlert DR (June 2006). "Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice". Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology 31 (6): 1135–45. PMID 16205780. doi:10.1038/sj.npp.1300913. 
  8. Roy M, David N, Cueva M, Giorgetti M (January 2007). "A study of the involvement of melanin-concentrating hormone receptor 1 (MCHR1) in murine models of depression". Biological Psychiatry 61 (2): 174–80. PMID 16934771. doi:10.1016/j.biopsych.2006.03.076. 
  9. Saito Y, Nagasaki H (2008). "The melanin-concentrating hormone system and its physiological functions". Results and Problems in Cell Differentiation 46: 159–79. PMID 18227983. doi:10.1007/400_2007_052. 
  10. Audinot V, Lahaye C, Suply T, Beauverger P, Rodriguez M, Galizzi JP, Fauchère JL, Boutin JA (June 2001). "[125I]-S36057: a new and highly potent radioligand for the melanin-concentrating hormone receptor". British Journal of Pharmacology 133 (3): 371–8. PMC 1572795. PMID 11375253. doi:10.1038/sj.bjp.0704085. 
  11. Able SL, Ivarsson M, Fish RL, Clarke TL, McCourt C, Duckworth JM, Napier C, Katugampola SD (June 2009). "Localisation of melanin-concentrating hormone receptor 1 in rat brain and evidence that sleep parameters are not altered despite high central receptor occupancy". European Journal of Pharmacology 616 (1-3): 101–6. PMID 19540226. doi:10.1016/j.ejphar.2009.06.009. 
  12. Chaki S, Yamaguchi J, Yamada H, Thomsen W, Tran TA, Semple G, Sekiguchi Y (2005). "ATC0175: an orally active melanin-concentrating hormone receptor 1 antagonist for the potential treatment of depression and anxiety". CNS Drug Reviews 11 (4): 341–52. PMID 16614734. 
  13. Gehlert DR, Rasmussen K, Shaw J, Li X, Ardayfio P, Craft L, Coskun T, Zhang HY, Chen Y, Witkin JM (May 2009). "Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression". The Journal of Pharmacology and Experimental Therapeutics 329 (2): 429–38. PMID 19182070. doi:10.1124/jpet.108.143362. 
  14. Doggrell SA (June 2003). "Does the melanin-concentrating hormone antagonist SNAP-7941 deserve 3As?". Expert Opinion on Investigational Drugs 12 (6): 1035–8. PMID 12783607. doi:10.1517/13543784.12.6.1035. 
  15. David DJ, Klemenhagen KC, Holick KA, Saxe MD, Mendez I, Santarelli L, Craig DA, Zhong H, Swanson CJ, Hegde LG, Ping XI, Dong D, Marzabadi MR, Gerald CP, Hen R (April 2007). "Efficacy of the MCHR1 antagonist N-[3-(1[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis". The Journal of Pharmacology and Experimental Therapeutics 321 (1): 237–48. PMID 17237257. doi:10.1124/jpet.106.109678. 
  16. Takekawa S, Asami A, Ishihara Y, Terauchi J, Kato K, Shimomura Y, Mori M, Murakoshi H, Kato K, Suzuki N, Nishimura O, Fujino M (March 2002). "T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist". European Journal of Pharmacology 438 (3): 129–35. PMID 11909603. doi:10.1016/S0014-2999(02)01314-6. 

Literatura[uredi - уреди | uredi izvor]